History- Description, length of time present, symptoms, previous skin cancers, immunosuppressants, FH skin cancer, sun exposure, change over time

Examination - Pigmented lesions - Glasgow 7 point
Checklist +/- ulceration, symmetry
 
WORKFORCE FUNCTIONS
Please refer to the supplementary information where the functions have been outlined of the Primary Assessment, Diagnostics and Treatments
 
Service improvement tools to help improve the pathway are available on the No Delays Achiever, & help to identify blocks & barriers along the pathway. Maximum Impact -Shorter Pathways outlines steps that can be taken to improve efficiency of pathways & services.
 

TECHNOLOGY
Electronic Patient Assessment Questionnaire is an example of a technology that can help measure the patients quality of life before referral to specialist care and following treatment.
 
For points to consider before commissioning see the supplementary information. For support in commissioning successfully and identifying opportunities for service redesign see the No Delays Achiever.
2.0 Primary Assessment
 
(eg Interface services - Unless only treating benign skin lesions this should be part of the local skin cancer LSMDT in an appropriate setting).
History & Examination: Clarification & expansion of primary assessment history & examination where needed, straight to diagnostic test or face to face assessment / examination
 
WORKFORCE FUNCTIONS
Please refer to the supplementary information where the functions have been outlined of the Primary Assessment, Diagnostics and Treatments
 
Service improvement tools to help improve the pathway are available on the No Delays Achiever, & help to identify blocks & barriers along the pathway. Maximum Impact -Shorter Pathways outlines steps that can be taken to improve efficiency of pathways & services.

 

TECHNOLOGY
Electronic Patient Assessment Questionnaire is an example of a technology that can help measure the patients quality of life before referral to specialist care and following treatment.
 
For support in commissioning successfully and identifying opportunities for service redesign see the No Delays Achiever.
3.0 Specialist Assessment
 
(eg. Specialist O/P or Tertiary Services)
History & Examination - Clarification & expansion of specialist assessment history and examination where needed, straight to diagnostic test or face to face assessment/examination

 
WORKFORCE FUNCTIONS
Please refer to the supplementary information where the functions have been outlined of the Primary Assessment, Diagnostics and Treatments
 
Service improvement tools to help improve the pathway are available on the No Delays Achiever, & help to identify blocks & barriers along the pathway. Maximum Impact -Shorter Pathways outlines steps that can be taken to improve efficiency of pathways & services.
 


TECHNOLOGY
Electronic Patient Assessment Questionnaire is an example of a technology that can help measure the patients quality of life before referral to specialist care and following treatment.
 
For support in commissioning successfully and identifying opportunities for service redesign see the No Delays Achiever.
4.0 Subspecialist Assessment
 
Changing / worrying skin growth / mole, non-healing skin lesion
1.1 Symptom Description
 
8,000 Malignant melanoma per year UK
1.2 Incidence & Prevalence
 

(Supported/Unsupported)

eg. NHS Direct (Internet or Phone); Pharmacy

History
 

Can Pharmacy be used to deliver and support self assessment and self care and underpin the service pathway? Have you thought of using existing published frameworks to support self care such as for the management of obesity?
1.3 Self Assessment & Self Care
 
Disease Prevention
Health Protection
Health Promotion
1.4 Primary Prevention
2.1 Dx thresholds & decision aids
3.1 Dx thresholds & decision aids
4.1 Dx thresholds & decision aids
 
As per 1.1
1.7 Red Flags
 
Suspected MM or SCC
2.7 Red Flags
3.7 Red Flags
2.2.1 No diagnostic required
 

Consider Telemedicine link to dermatology unit
2.2.2 Telemedicine
2.2.3 Diagnostic Biopsy
 


Triage thresholds
Decision Aids
1.6 Escalation thresholds & decision aids
 


 




Case Study available
2.6 Escalation thresholds, QOL meas., decision aids, remote advice
3.6 Escalation thresholds & decision aids
 



When confident benign lesion
2.4.1 Information reassurance self help
 

Clinically benign lesion but patient says changing - review
2.4.2 Active monitoring
 

Topical treatmnt +/- cryotherapy
2.4.4 Medication
 
Within local low priority frameworks
2.4.6 Invasive Tx
 

Good practice available
 

2.4.5 Initial Preop. Assess.
3.2.1 No diagnostic required
3.2.2 Diagnostic Biopsy
3.2.3 Dermoscopy
4.2.1 No diagnostic required
 
Additional biopsies as required
4.2.2 Biopsy
 



When confident benign lesion discharge back to the GP no treatment. Patient info
3.4.1 Information reassurance self help
 

Clinically benign lesion but patient says changing - review by appropriate practitioner
3.4.2 Active monitoring
3.4.3 Physical & psych. therapy
 

Topical treatments, cryotherapy, PDT and radiotherapy
3.4.4 Medication
 
Excision, curettage and cautery
3.4.6 Invasive Tx
 

Yes
 

Good practice available
 

3.4.5 Preop. Assess.
 



Psycholog -ical support
4.4.3 Physical & psych. therapy
4.4.4 Non-Surgical Tx
 
As 3.4.6 +
-Excision
-Excision + reconstruction
-Micrographic surgery
4.4.6 Invasive Tx
 

Yes
 

4.4.5 Preop. Assess.
 



EQ5D
2.3 QoL, Treatment thresholds & Decision Aids
 



EQ5D
3.3 QoL, Treatment thresholds & Decision Aids
 



EQ5D
4.3 QoL, Treatment thresholds & Decision Aids
Metric
Metric
Metric
 




2.2 Diagnostics (Dx)
3.2 Diagnostics (Dx)
4.2 Diagnostics (Dx)
2.4 Treatments (Tx)
3.4 Definitive Treatments (Tx)
4.4 Definitive Treatments (Tx)
Pathway template design copyright © S Laitner and S Normanton 2007 at Pathwaysforhealth.org, all rights reserved.
Terms and Conditions apply
 
WORKFORCE
 
SERVICE IMPROVEMENT AND MODELS OF CARE
 
COMMISSIONING AND CONTRACTING
 
TECHNOLOGY AND EQUIPMENT
Elective Care Commissioning Pathway - Skin Lesion 2008
 

1.0 Changing skin
5.0
 
Quality of Life (QoL) Outcome Measurement
 
Generic Patient Reported Outcome Measures exist for this pathway (EQ5D). Currently clinical consensus has not been reached for a condition specific measure.
2.5 Rehabilitation & Review
 
Generic Patient Reported Outcome Measures exist for this pathway (EQ5D). Currently clinical consensus has not been reached for a condition specific measure.
3.5 Rehabilitation, Review & QOL measurement
 
Generic Patient Reported Outcome Measures exist for this pathway (EQ5D). Currently clinical consensus has not been reached for a condition specific measure.
4.5 Rehabilitation, Review & QOL measurement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drag Bar
XPath: Viewer Menu
Pathway Information
Name:
Mode:
Revision:
Show Pathway Layer
 
   
Drag Bar
XPath: Feedback Manager
Element Title
 Ref  Heading
 
Feedback